As parents we were frustrated and dissatisfied with the status quo of going into the clinic to get checked for strep. We imagined a world where we were empowered with a diagnostic that would confirm strep throat and allow us to receive a treatment plan from a virtual care provider. We couldn't find our solution so we're building it, The FoxOwl™ Rapid Strep Platform.
We are in the process of developing a test cassette and digital platform to diagnose and treat strep throat from home without having to go in and see a provider.
Every parent is familiar with the struggles that come when our kids come down with a sore throat and fever. We have two options, watchfully wait the symptoms or pack them up and bring them into the provider to be checked for strep.
50 million people a year go into the doctor for the condition of sore throat, it is the #1 reason parents bring their children into a provider and 75% of the time the visit is unnecessary because the symptoms are a viral infection.
Since 1968 parents have been going to the doctor's office to diagnose strep throat. It's a massive economic and time burden on parents, providers and payers.
Our test cassette is designed to a be an easy-to-use consumer product. It is a lateral flow test the same technology of a pregnancy test. The parent takes the sample with a swab, places the swab in the cassette, closes the cassette door to pop the reagent blisters and then the reagents flow down to the reader window and in minutes the parents has the results.
The FoxOwl™ Rapid Strep Test is sold in sets of 2, allow the parent to retest in 24 hours if the child's symptoms progress.
The digital platform serves multiple purposes for the consumer and FDA. The function of the platform is to train and assess parents on how to take an accurate sample through the use of video and confirm single use of a positive diagnosis for virtual care providers. With a positive diagnosis the user will automatically be routed to a virtual care provider and pharmacy provider of their choice. If the test is negative the platform will stay in touch with user to check-in and ask if the symptoms have progressed, stayed the same or subsided.
Founder and CEO
Chief Strategy Officer
Director of Regulatory Affairs
Sign up to receive our newsletter and announcements